Guangdong, China

Ji Zhou


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ji Zhou - Innovator in Immunology

Introduction

Ji Zhou is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 3 patents, Ji Zhou is recognized for his work in developing novel immune agonists and antibodies.

Latest Patents

One of Ji Zhou's latest patents focuses on immune agonists. This application presents a novel series of small molecular immune agonists of Toll-like receptor, characterized by a specific structure represented by Formula I. The patent further details the use of these immune agonists for activating and amplifying immune cells and lymphocytes. It also discusses their potential in preparing immunomodulatory drugs, immune anti-tumor small molecule drugs, and immune anti-tumor macromolecular drugs.

Another significant patent involves the development of recombinant chicken IgY monoclonal antibodies and scFv antibodies raised against human thymidine kinase 1 expressed in mammalian cells. This patent discloses the preparation method and use of these antibodies, which include specific amino acid sequences for both the light and heavy chains of the scFv antibody.

Career Highlights

Ji Zhou has worked with notable organizations, including Sino-Swed Tongkang Bio-Tech (Shenzhen) Limited and Shenzhen University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Ji Zhou has collaborated with esteemed colleagues, including Zuosheng Li and Hu Chen. These partnerships have further enriched his research endeavors and innovations in immunology.

Conclusion

Ji Zhou's contributions to immunology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in immunotherapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…